In recent years, several studies have shown the importance of both the gut and the tumor microbiome in cancer...
Microbiomes & cancer Articles
Microbiomes appear as a new source of therapeutic strategies to expand the efficacy and adherence to ICI treatments. More
read more
Several studies have shown the importance of the gut microbiota in cancer progression and treatment response. More
The human tumor microenvironment is colonized by cancer type–specific bacteria and fungi
Several studies have shown the importance of the gut microbiota in cancer progression and treatment response. Although...
Immunotherapy has revolutionized the treatment of several cancers. However, it remains elusive why only some patients benefit from these treatments and why some patients experience immune-related adverse events (irAEs). More
Microbiomes modulate the local immune response, influencing immunotherapy response and toxicity
Immunotherapy has revolutionized the treatment of several cancers. However, it remains elusive why only some patients...
Immunotherapies (Immune Checkpoint Inhibitors, ICI) have become a powerful therapeutic strategy for treating a variety of cancers. It is a very exciting area, but with challenges. Indeed, the patients’ response to these therapies is often heterogeneous and not durable, with only 20 to 40% of patients actually responding. More
Resistance to anti-PD-1 immunotherapy can be attributed to the gut microbiome
Immunotherapies (Immune Checkpoint Inhibitors, ICI) have become a powerful therapeutic strategy for treating a variety...
Numerous metagenomics-based studies have associated gut microbiota dysbiosis with the progression and resistance to immunotherapy of intestinal and non-intestinal cancers. more
Gut microbiota dysbiosis contributes to the tumorigenic process, even in extra-intestinal malignancies
Numerous metagenomics-based studies have associated gut microbiota dysbiosis with the progression and resistance to...